Literature DB >> 10896784

Phosphorylation of the beta1 integrin cytoplasmic domain: toward an understanding of function and mechanism.

J Mulrooney1, K Foley, S Vineberg, M Barreuther, L Grabel.   

Abstract

As F9 stem cells differentiate into parietal endoderm they form focal adhesion sites. There is a concomitant decrease in the level of phosphorylation of S785 in the cytoplasmic domain of the beta1 integrin subunit. Previous transfection studies demonstrate that site-specific mutations at this residue, mimicking different phosphorylation states, can alter the subcellular localization of the subunit in differentiating F9 cells. We now extend these observations in an attempt to substantiate the function of beta1 phosphorylation and determine how the phosphorylation levels are regulated. We show that treatment of parietal endoderm with okadaic acid induces an increase in beta1 phosphorylation and selective loss of beta1 from focal adhesion sites. Using a PCR approach, we identify two phosphatases expressed in parietal endoderm, including PP2A. Using a crosslinking approach, where antibodies are added to live cells, we show that the catalytic subunit of PP2A co-immunoprecipitates with beta1. Immunocytochemistry shows PP2A colocalizing to focal adhesion sites with beta1. In addition integrin-linked kinase (ILK) co-immunoprecipitates with beta1 in parietal endoderm and localizes to focal adhesion sites. Okadaic acid treatment significantly decreases the level of ILK associated with beta1. A possible role for regulated beta1 phosphorylation in cell migration is discussed. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896784     DOI: 10.1006/excr.2000.4964

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Differential regulation of a novel variant of the alpha(6) integrin, alpha(6p).

Authors:  Tracy L Davis; Friederike Buerger; Anne E Cress
Journal:  Cell Growth Differ       Date:  2002-03

2.  Increased extracellular pressure enhances cancer cell integrin-binding affinity through phosphorylation of beta1-integrin at threonine 788/789.

Authors:  David H Craig; Christopher P Gayer; Keri L Schaubert; Yanzhang Wei; Jinhua Li; Yasmina Laouar; Marc D Basson
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-12       Impact factor: 4.249

3.  Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.

Authors:  Nuzhat Ahmed; Clyde Riley; Greg Rice; Michael Quinn
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  Role of the cytoplasmic tyrosines of beta 1A integrins in transformation by v-src.

Authors:  T Sakai; R Jove; R Fässler; D F Mosher
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

5.  Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1.

Authors:  C Leung-Hagesteijn; A Mahendra; I Naruszewicz; G E Hannigan
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

6.  Integrin alpha 2 beta 1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta.

Authors:  Johanna Ivaska; Liisa Nissinen; Nina Immonen; John E Eriksson; Veli-Matti Kähäri; Jyrki Heino
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

7.  WAVE2 Protein Complex Coupled to Membrane and Microtubules.

Authors:  Kazuhide Takahashi
Journal:  J Oncol       Date:  2012-01-18       Impact factor: 4.375

8.  Staurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction - a model for cross-modulation.

Authors:  Honor J Hugo; Razan Wafai; Tony Blick; Erik W Thompson; Donald F Newgreen
Journal:  BMC Cancer       Date:  2009-07-15       Impact factor: 4.430

9.  QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model.

Authors:  Jessica Kalra; Corinna Warburton; Karen Fang; Lincoln Edwards; Tim Daynard; Dawn Waterhouse; Wieslawa Dragowska; Brent W Sutherland; Shoukat Dedhar; Karen Gelmon; Marcel Bally
Journal:  Breast Cancer Res       Date:  2009-05-01       Impact factor: 6.466

10.  Midkine is neuroprotective and influences glial reactivity and the formation of Müller glia-derived progenitor cells in chick and mouse retinas.

Authors:  Warren A Campbell; Amanda Fritsch-Kelleher; Isabella Palazzo; Thanh Hoang; Seth Blackshaw; Andy J Fischer
Journal:  Glia       Date:  2021-02-10       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.